TYK Medicines Inc2410
Mentioned

As of July 31, 2026, Tigermed has repurchased 20.96 million shares, accounting for 2.4347% of total share capital, with a total repurchase amount of 824 million yuan and a repurchase price range of 38.22 yuan to 42.78 yuan per share. In the first quarter of 2026, the company achieved revenue of 1.801 billion yuan and net profit attributable to the parent of 49.04 million yuan.
TYK Medicines Inc
Hangzhou Tigermed ConsultingCompany repurchased shares, indicating confidence and supporting stock price.